References
- Franks S. Polycystic ovary syndrome. N EnglJ Med 1995;333:853–61
- Homburg R, Amsterdam A. Polycystic ovary syn-drome — loss of the apoptotic mechanism in the ovarian follicles?J Endocrinol Invest 1998;21:552–7
- Naylor MS, Stamp GW, Foulkes WD, etal. Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression. J Clin Invest 1993;91:2194–206
- Roby KF, Weed J, Lyles R, et al. Immunological evidence for a human ovarian tumor necrosis factor-alpha. J Clin Endocrinol Metab 1990;71: 1096–102
- Zolti M, Meirom R, Shemesh M, et al. Granulosa cells as a source and target organ for tumor necrosis factor-alpha. FEBS Lett 1990;261:253–5
- Gonzalez F, Thusu K, Abdel-Rahman E, et al. Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome. Metabolism 1999;48:437–41
- Escobar-Morreale H, Calvo R, Sancho J, et al. TNF-a and hyperandrogenism: a clinical, bio-chemical, and molecular genetic study. J Clin Endo-crinol Metab 2001;86:3761–7
- Peltonen L, Jalanko A, Varilo T. Molecular genetics of the Finnish disease heritage. Hum Mol Genet 1999;8:1913–23
- Ferriman D, Gallwey J. Clinical assessment of bo dy hair growth in women. J Clin Endocrinol Metab 1961;21:1440–7
- Kato T, Honda M, Kuwata S, et al. Novel poly-morphism in the promoter region of the tumor necrosis factor alpha gene. No association with narcolepsy. Am J Genet 1999;88:301–4
- Franks S, Gharani N, McCarthy M. Candidate genes in polycystic ovary syndrome. Hum Reprod Update 2001;7:405–10
- Milner CR, Craig JE, Hussey ND, etal. No associ-ation between the —308 polymorphism in the tumour necrosis factor alpha (TNFalpha) promoter region and polycystic ovaries. Mol Hum Reprod 1999;5:5–9
- Urbanek M, Legro RS, Driscoll DA, etal. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Natl Acad Sci USA 1999;96:8573–8